24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
We are proud to announce our top 20 position as a great place to work for well-being. At Oxford PharmaGenesis, we have a caring and nurturing culture, and we look out for each other, so this accolade is the work of many. We would like to take this opportunity to especially thank the efforts of…
To find information about medicine, people search databases that contain articles related to the topic. Many literature databases tag articles to help to categorize the type of publication. This helps users to access relevant information more easily. For example, if someone is looking for a report about a clinical trial or a review to get…
DPhil student, Dr Amy Booth (University of Oxford) and Oxford PharmaGenesis CEO, Dr Chris Winchester, have co-authored a new study published in the International Journal of Environmental Research and Public Health this month, revealing the climate change targets of the 20 leading global pharmaceutical companies – and how they are reporting on and reducing their…
Oxford PharmaGenesis has secured Great Place to Work® accreditation for a third consecutive year in the UK and a seventh consecutive year in the US. This was awarded based on average scores across a number of statements and 90% of colleagues who responded to the survey agreed that “Taking everything into account, I would say this is a great place to work”.
The ISMPP EU conference took place in London on 24–25 January. Themed around ‘Fueling Creativity’, sessions explored how to access creativity, improve collaboration and arrive at unexpected solutions.
Join our healthy debate at the 2023 European Meeting of ISMPP and explore new frontiers with Oxford PharmaGenesis.
